isoniazid has been researched along with vancomycin in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.38) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 11 (26.19) | 29.6817 |
2010's | 22 (52.38) | 24.3611 |
2020's | 6 (14.29) | 2.80 |
Authors | Studies |
---|---|
Freyer, AJ; Killmer, LB; Porter, JR; Zgoda, JR | 1 |
Freyer, AJ; Killmer, LB; Porter, JR; Zgoda-Pols, JR | 1 |
Billington, DC; Coleman, MD; Lambert, PA; Parker, KJ; Rathbone, DL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Agrawal, B; Desroches, N; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Tse, C | 1 |
Biswas, K; Crick, DC; Dhiman, R; Kurosu, M; Narayanasamy, P | 1 |
Barbachyn, MR; Brickner, SJ; Hutchinson, DK; Manninen, PR | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Dawson, MN; Demaray, JA; Sucheck, SJ; Thuener, JE | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Berrue, F; Haltli, B; Kerr, RG; McCulloch, MW | 1 |
Bao, L; Cai, L; Chen, JL; Huang, P; Liu, HW; Liu, MM; Qi, QY; Wang, QX; Yang, JL; Yang, XL; Zhang, LX | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Banerjee, B; Cushman, M; Franzblau, SG; Ghafoor, A; Hamed, MI; Lv, W; Mesecar, AD; Molland, KL; Seleem, MN; Wan, B | 1 |
Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Agrawal, B; Garg, S; Kumar, R; Kunimoto, DY; Shakya, N; Srivastav, NC | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
Benková, M; Hrabálek, A; Karabanovich, G; Kavková, V; Klimešová, V; Konečná, K; Macháček, M; Němeček, J; Roh, J; Soukup, O; Stolaříková, J; Sychra, P; Vávrová, K | 1 |
Borra, RS; Chopra, S; Das, S; Dasgupta, A; Gatadi, S; Gour, J; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
Abdel Gawad, NM; Abdel-Aziz, MM; Abo-Ashour, MF; Abou-Seri, SM; Bhakta, S; Elaasser, MM; Eldehna, WM; George, RF; Gupta, A | 1 |
Eswaran, S; Narayanan, S; Shivarudraiah, P; Shruthi, TG; Subramanian, S | 1 |
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Caljon, G; Cappoen, D; Claes, P; Cools, F; Cos, P; De Kimpe, N; de Macedo, MB; Delputte, P; Holvoet, F; Maes, L; Mangelinckx, S; Matheeussen, A; Meiresonne, T; Neyrolles, O; Piller, T; Semina, E; Torfs, E; Van Calster, K | 1 |
Augustynowicz-Kopeć, E; Bojanowski, K; Foks, H; Gobis, K; Głogowska, A; Korona-Głowniak, I; Krause, M; Siluk, D; Ziembicka, D | 1 |
Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C | 1 |
Jackson, EA; McLeod, DC | 1 |
Górmiński, BM; Lisowska, K; Sedlaczek, L | 1 |
Omura, S | 1 |
Gkiatas, K; Kararizos, G; Kararizou, E; Likomanos, D; Markou, I; Triantafyllou, N; Vassilopoulos, D; Zalonis, I; Zambelis, T | 1 |
DeJesus, MA; Ehrt, S; Engelhart, CA; Healy, C; Ioerger, TR; Lin, K; Park, SW; Rücker, N; Schnappinger, D; Wang, R; Wright, MG; Xu, W | 1 |
Boldrin, F; Espinosa, DM; Hernandez-Pando, R; Manganelli, R; Palù, G; Payan, JB; Pisu, D; Provvedi, R | 1 |
Cizek, A; Hosek, J; Imramovsky, A; Jampilek, J; Magar, P; Michnova, H; Pauk, K; Pilarova, E; Pindjakova, D | 1 |
3 review(s) available for isoniazid and vancomycin
Article | Year |
---|---|
Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones | 2008 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Antiinfective drugs into the 21st century].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Adhesion; Bacterial Physiological Phenomena; Forecasting; Genome, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Staphylococcus aureus; T-Lymphocytes; Vancomycin | 1999 |
39 other study(ies) available for isoniazid and vancomycin
Article | Year |
---|---|
Polyacetylene carboxylic acids from Mitrephora celebica.
Topics: Acetylene; Alkynes; Annonaceae; Anti-Bacterial Agents; Carboxylic Acids; Diynes; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Indonesia; Magnetic Resonance Spectroscopy; Methicillin; Molecular Structure; Mycobacterium smegmatis; Plant Stems; Plants, Medicinal; Polymers; Polyynes; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus | 2001 |
Antimicrobial resveratrol tetramers from the stem bark of Vatica oblongifoliassp. oblongifolia.
Topics: Ericales; Malaysia; Methicillin Resistance; Molecular Conformation; Molecular Structure; Mycobacterium smegmatis; Nuclear Magnetic Resonance, Biomolecular; Plant Stems; Plants, Medicinal; Resveratrol; Staphylococcus aureus; Stilbenes | 2002 |
Discovery of a potent phenolic N1-benzylidene-pyridinecarboxamidrazone selective against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Humans; Leukocytes; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Structure-Activity Relationship | 2006 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Line; Cell Survival; Chlorocebus aethiops; Drug Resistance, Bacterial; Floxuridine; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Rifampin; Structure-Activity Relationship | 2007 |
Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.
Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Benzophenones; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Mycobacterium; Naphthols; Staphylococcus aureus; Staphylococcus epidermidis | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Enterococcus faecalis; Microbial Sensitivity Tests; Mycobacterium smegmatis; Oxazolidinones; Triazoles | 2008 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
One-pot syntheses of pseudopteroxazoles from pseudopterosins: a rapid route to non-natural congeners with improved antimicrobial activity.
Topics: Anti-Bacterial Agents; Diterpenes; Enterococcus faecium; Glycosides; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Staphylococcus aureus; Stereoisomerism; Vancomycin | 2011 |
3-Anhydro-6-hydroxy-ophiobolin A, a new sesterterpene inhibiting the growth of methicillin-resistant Staphylococcus aureus and inducing the cell death by apoptosis on K562, from the phytopathogenic fungus Bipolaris oryzae.
Topics: Apoptosis; Cell Death; Drug Screening Assays, Antitumor; Flow Cytometry; Hep G2 Cells; Humans; K562 Cells; Methicillin-Resistant Staphylococcus aureus; Oryza; Sesterterpenes; Structure-Activity Relationship | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.
Topics: Anti-Bacterial Agents; High-Throughput Screening Assays; Inorganic Pyrophosphatase; Mycobacterium tuberculosis; Staphylococcus aureus; Structure-Activity Relationship; Triazines | 2014 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium Infections; Nucleosides; Pyrimidines; Structure-Activity Relationship | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Species Specificity; Structure-Activity Relationship; Tetrazoles | 2017 |
Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Staphylococcal Infections; Structure-Activity Relationship; Triazoles | 2018 |
Novel indole-thiazolidinone conjugates: Design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Dose-Response Relationship, Drug; Drug Design; Fungi; Humans; Indoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Phenotype; RAW 264.7 Cells; Structure-Activity Relationship; Thiazolidines | 2018 |
Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Benzophenanthridines; Cell Line; Dose-Response Relationship, Drug; Humans; Hydrocarbons, Fluorinated; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2019 |
4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Thiosemicarbazones; Yeasts | 2020 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
Antimicrobial and Cytotoxic Angucyclic Quinones from
Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones | 2021 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
Effect of inhibitors of cell envelope synthesis on beta-sitosterol side chain degradation by Mycobacterium sp. NRRL MB 3683.
Topics: Biotransformation; Cell Membrane; Cell Wall; Cycloserine; Ethambutol; Glycine; Isoniazid; Mycobacterium; Norleucine; Penicillins; Peptidoglycan; Phenylalanine; Sitosterols; Vancomycin | 1994 |
Paraneoplastic limbic encephalitis presenting as acute viral encephalitis.
Topics: Acute Disease; Acyclovir; Anti-Bacterial Agents; Anticonvulsants; Carcinoma, Renal Cell; Cerebrospinal Fluid; Diagnosis, Differential; Drug Therapy, Combination; Electroencephalography; Encephalitis, Viral; Enoxaparin; Ethambutol; Follow-Up Studies; Herpesvirus 1, Human; Humans; Isoniazid; Limbic Encephalitis; Limbic System; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Middle Aged; Nephrectomy; Neuropsychological Tests; Paraneoplastic Syndromes, Nervous System; Phenytoin; Rifampin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2005 |
Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Bacterial Proteins; Cell Wall; Drug Resistance, Multiple, Bacterial; Ethambutol; Galactans; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Ion Pumps; Isoniazid; Ligases; Mannosyltransferases; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Peptidoglycan; Rifampin; Serine Proteases; Thienamycins; Vancomycin | 2017 |
The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Tolerance; Ethambutol; Gene Expression Regulation, Bacterial; Gentamicins; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Rifampin; Sigma Factor; Streptomycin; Vancomycin | 2017 |
Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics.
Topics: Ampicillin; Anilides; Anti-Bacterial Agents; Benzamides; Humans; Isoniazid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptidomimetics; Salicylanilides; Vancomycin | 2022 |